
Amazon Makes Third Attempt to Disrupt Healthcare Business
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
The Miami-based startup has secured major in-home phlebotomy services contracts from some of the nation’s biggest lab companies.
The developer of NGS-based companion diagnostics targets the growing neurology biomarker market.
The Hilden, Germany-based company is extending its genetic testing profile beyond oncology to neurology biomarkers.
In July, ICATT took a major step toward equitable access to testing by enlisting two of the country’s leading COVID-19 PCR test providers.